CN1471580A - 含有外源性内表位的病毒颗粒 - Google Patents

含有外源性内表位的病毒颗粒 Download PDF

Info

Publication number
CN1471580A
CN1471580A CNA008167532A CN00816753A CN1471580A CN 1471580 A CN1471580 A CN 1471580A CN A008167532 A CNA008167532 A CN A008167532A CN 00816753 A CN00816753 A CN 00816753A CN 1471580 A CN1471580 A CN 1471580A
Authority
CN
China
Prior art keywords
peptide
virus
epi
virus particle
exogenous peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA008167532A
Other languages
English (en)
Chinese (zh)
Inventor
K
K·海伦多恩
T·琼斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of CN1471580A publication Critical patent/CN1471580A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA008167532A 1999-10-14 2000-10-13 含有外源性内表位的病毒颗粒 Pending CN1471580A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924352.9A GB9924352D0 (en) 1999-10-14 1999-10-14 Methods,compositions and applications relating to the generation of novel plant viral particles
GB9924352.9 1999-10-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA2009101426265A Division CN101591647A (zh) 1999-10-14 2000-10-13 含有外源性内表位的病毒颗粒

Publications (1)

Publication Number Publication Date
CN1471580A true CN1471580A (zh) 2004-01-28

Family

ID=10862753

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA008167532A Pending CN1471580A (zh) 1999-10-14 2000-10-13 含有外源性内表位的病毒颗粒
CNA2009101426265A Pending CN101591647A (zh) 1999-10-14 2000-10-13 含有外源性内表位的病毒颗粒

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2009101426265A Pending CN101591647A (zh) 1999-10-14 2000-10-13 含有外源性内表位的病毒颗粒

Country Status (16)

Country Link
EP (1) EP1235910A1 (fr)
JP (1) JP2003534771A (fr)
KR (1) KR100880477B1 (fr)
CN (2) CN1471580A (fr)
AR (1) AR026066A1 (fr)
AU (1) AU785020B2 (fr)
BR (1) BR0014861A (fr)
CA (1) CA2387626A1 (fr)
CO (1) CO5280142A1 (fr)
CZ (1) CZ20021303A3 (fr)
GB (1) GB9924352D0 (fr)
IL (1) IL149077A0 (fr)
MX (1) MXPA02003789A (fr)
PL (1) PL354933A1 (fr)
WO (1) WO2001027282A1 (fr)
ZA (1) ZA200202815B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000855A2 (fr) * 2001-06-21 2003-01-03 Uab Research Foundation Proteines de capsides chimeriques et leurs utilisations
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
MXPA05000287A (es) 2002-07-05 2005-09-08 Leclerc Denis Particula viral adyuvante.
GB2434367B (en) 2004-10-05 2010-05-12 Diversa Corp Improved vaccines
CA2608515A1 (fr) * 2005-06-01 2007-05-10 Dow Global Technolgies Inc. Production de particules multivalentes semblables a des virus
BRPI0613625A2 (pt) * 2005-07-19 2011-01-18 Dow Global Technologies Inc vacinas da gripe recombinantes
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配
WO2013003353A2 (fr) * 2011-06-30 2013-01-03 Stc.Unm Plasmides et procédés pour la présentation de peptide et sélection par affinité sur des particules de type virus de bactériophages à arn

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108386D0 (en) * 1991-04-19 1991-06-05 Agricultural Genetics Co Modified plant viruses as vectors
GB9712282D0 (en) * 1997-06-12 1997-08-13 Innes John Centre Innov Ltd Epitope presentation system

Also Published As

Publication number Publication date
JP2003534771A (ja) 2003-11-25
PL354933A1 (en) 2004-03-22
AR026066A1 (es) 2002-12-26
CO5280142A1 (es) 2003-05-30
EP1235910A1 (fr) 2002-09-04
BR0014861A (pt) 2002-07-16
WO2001027282A1 (fr) 2001-04-19
WO2001027282A8 (fr) 2001-08-16
KR20020040868A (ko) 2002-05-30
CN101591647A (zh) 2009-12-02
AU785020B2 (en) 2006-08-24
ZA200202815B (en) 2003-08-27
MXPA02003789A (es) 2002-09-30
IL149077A0 (en) 2002-11-10
AU1085201A (en) 2001-04-23
GB9924352D0 (en) 1999-12-15
CA2387626A1 (fr) 2001-04-19
CZ20021303A3 (cs) 2002-10-16
KR100880477B1 (ko) 2009-01-28

Similar Documents

Publication Publication Date Title
CN103031310B (zh) 在植物中表达蛋白质
CN109321582B (zh) 粗山羊草Yr4DS基因在麦族植物抗条锈病育种的应用
KR102162118B1 (ko) 식물에서 로타바이러스-유사 입자 생산
CN1927394A (zh) 口服重组幽门螺杆菌疫苗及其制备方法
KR20100044813A (ko) 돼지 부종병 백신
US20210388366A1 (en) Plant-produced chimaeric orbivirus vlps
CN111727255A (zh) 修饰后诺如病毒vp1蛋白和包含修饰后诺如病毒vp1蛋白的vlp
CN1471580A (zh) 含有外源性内表位的病毒颗粒
CN1923850A (zh) 水稻叶形控制基因sll1及其应用
CA2745620A1 (fr) Plante de soja transformee qui stocke un vaccin, et utilisation de celle-ci
CN1079779A (zh) 新的植物启动子
CN1162979A (zh) Dna序列及其用途
CN1772902A (zh) 轮状病毒vp6蛋白的一种编码基因及其应用
WO2008035210A2 (fr) PARTICULES PSEUDO-VIRALES HBsAg RECOMBINANTES CONTENANT DES POLYÉPITOPES D'INTÉRÊT, LEUR PRODUCTION ET LEUR UTILISATION
CN1229139A (zh) 葡萄糖氧化酶基因在培育抗病转基因植物中的应用
CN112813092B (zh) GbBCCP5蛋白质及其编码基因在调控生物油脂含量中的应用
CN101988058B (zh) 一种基因表达组合物、猪生殖与呼吸道综合症口服疫苗及其制备方法
CN1379783A (zh) 通过功能性地抑制植物细胞周期蛋白抑制剂基因增加植物细胞增殖的方法
KR20170104595A (ko) 식물에서 로타바이러스-유사 입자 생산
US7135282B1 (en) Viral particles with exogenous internal epitopes
CN1280457A (zh) 葡萄树中的线虫传多面体病毒抗性
CN1110559C (zh) 调控金黄担子素敏感性的基因
CN1571839A (zh) 利用可见光修复紫外线损伤的dna的酶基因
TW202018084A (zh) 修飾之諾羅病毒vp1蛋白及包含修飾之諾羅病毒vp1蛋白之vlp
KR101560793B1 (ko) 비병원성 전염성낭병 변이 바이러스 및 이의 백신으로써의 용도

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication